Knowledge Center
Presentation / Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Source:
AAPS 2021
Track: Formulation and Delivery – Chemical
Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)
|
Presenting Author: Ricardo Gonçalves - Analytical Scientist, R&D Analytical Development
Why do we use small lactose particles to improve Dry Powder Inhaler formulations? Why sieved and milled lactose particles present different properties? This presentation explores the role of surface energetics, measured using inverse gas chromatography, in the behavior of DPI formulations and the implication on their aerodynamic performance.
Also in the Knowledge Center
/ Apr 25, 2017
Scale-up of a DPI carrier-based formulation and blending process optimization
Read more
Scientific Article
/ Apr 25, 2017
Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate
Read more
Scientific Article
/ Apr 25, 2017
Optimization of Formulation and Process Parameters for the Manufacture of Inhalable Composite Particles by Spray-Drying
Read more
Scientific Article